Merilog Receives FDA Approval as the First Rapid-Acting Insulin Biosimilar

The U.S. Food and Drug Administration (FDA) approved Merilog (insulin aspart szij) as a Novolog biosimilar to (insulin aspart) to improve glycemi...

February 20, 2025 | Thursday | News
3Z Pharmaceuticals Unveils Groundbreaking Study Supporting Amlodipine as a Novel Non-Stimulant ADHD Therapy

3Z Pharmaceuticals announced the publication of a transformative study in Neuropsychopharmacology, highlighting compelling scientific evidence that positio...

February 18, 2025 | Tuesday | News
Navi Medical Technologies' Neonav® ECG Tip Location System Receives FDA 510(k) Clearance for Pediatric Care

Navi Medical Technologies, a medical device company focused on pediatric healthcare innovation, proudly announces that its Neonav® ECG Tip Location Sys...

February 18, 2025 | Tuesday | News
Pfizer's TALZENNA® (talazoparib) + XTANDI® (enzalutamide) Combo Shows Significant Overall Survival Improvement in Metastatic Castration-Resistant Prostate Cancer

Pfizer Inc. announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP)...

February 14, 2025 | Friday | News
Thermo Fisher Scientific Launches Invitrogen™ EVOS™ S1000 Spatial Imaging System

WALTHAM, Mass. Thermo Fisher Scientific Inc., the world leader in serving science, introduced the Invitrogen™ EVOS™ S1000 Spatial Imaging Syste...

February 13, 2025 | Thursday | News
Kessler Foundation Achieves Breakthrough in Spinal Cord Injury Treatment with First Epidural Spinal Stimulator Implant

The Tim and Caroline Reynolds Center for Spinal Stimulation at Kessler Foundation is proud to announce the implantation of a spinal cord epidural stim...

February 12, 2025 | Wednesday | News
Bio X Cell Expands in China with New Beijing Distribution Center

Bio X Cell, the world's leading provider of functional antibodies for translational research, is strengthening its global distribution network with the o...

February 11, 2025 | Tuesday | News
GC Biopharma Presents Promising Updates on LSD Pipeline at WORLD Symposium 2025

GC Biopharma, a South Korean biopharmaceutical company, announced that it presented development updates on its LSD (lysosomal storage disorder) pipelines a...

February 11, 2025 | Tuesday | News
Merck Initiates Pivotal Phase 3 Trial of Zilovertamab Vedotin for Treatment of Diffuse Large B-Cell Lymphoma

Merck known as MSD outside of the United States and Canada, announced the initiation of waveLINE-010, a pivotal Phase 3 clinical trial evaluating ziloverta...

February 10, 2025 | Monday | News
Alumis and ACELYRIN Announce Definitive Merger Agreement, Creating a Leading Immunology Biopharma with Late-Stage Pipeline Strength

Alumis Inc. (Nasdaq: ALMS) and ACELYRIN, Inc. (Nasdaq: SLRN) today announced a definitive merger agreement, creating a powerhouse in immunology-focused b...

February 07, 2025 | Friday | News
BioMed X and Merck Reveal Critical Insights on Extrachromosomal DNA in Cancer Paving the Way for Novel Therapies

The research of BioMed X team EDC - Extrachromosomal DNA in Cancer - has uncovered critical insights into the mechanisms driving extrachromosomal ...

February 06, 2025 | Thursday | News
NeuFit Revolutionizes Neurological Rehabilitation with Innovative NEUBIE Device

 NeuFit is revolutionizing neurological rehabilitation with its innovative approach that integrates advanced diagnostics and therapeutic technolo...

February 06, 2025 | Thursday | News
Kodiak Sciences to Present Novel Glaucoma Treatment at Glaucoma 360 New Horizons Forum 2025

Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to tre...

February 05, 2025 | Wednesday | News
Medidata Advances AI-Powered Clinical Innovation to Transform Patient Care and Drug Development

-Medidata, a Dassault Systèmes brand, reaffirms its vision and commitment to advancing the life sciences industry and transforming patient experie...

February 04, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close